Showing results (21-30 of 71) with videos related to
Sort By:
Pageof 8
Journal for Immunotherapy of Cancer|January 22, 2024
CD8+ chimeric antigen receptor T cells manufactured in absence of CD4+ cells exhibit hypofunctional phenotypeSang Yun Lee, Dong Hoon Lee, Wei Sun, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 28, 2017
Preclinical Optimization of a CD20-specific Chimeric Antigen Receptor Vector and Culture ConditionsSang Yun Lee, Philip Olsen, Dong Hoon Lee, et al.Cancer Immunology, Immunotherapy : CII|July 30, 2022
Association of hepatitis B virus DNA levels with overall survival for advanced hepatitis B virus-related hepatocellular carcinoma under immune checkpoint inhibitor therapyMengchao An, Wenkang Wang, Jie Zhang, et al.Clinical Lymphoma, Myeloma & Leukemia|November 24, 2025
Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell LymphomaCarrie Ho, Neena Kennedy, Mengyang Di, et al.British Journal of Haematology|October 23, 2015
Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601Brian G Till, Hongli Li, Steven H Bernstein, et al.Journal of the National Cancer Institute|January 2, 2017
Recommendations for Clinical Trial Development in Mantle Cell LymphomaStephen E Spurgeon, Brian G Till, Peter Martin, et al.JCO Oncology Practice|November 18, 2024
Clinical Relevance of Intensive Laboratory Monitoring With Standard Venetoclax Ramp-Up for Chronic Lymphocytic Leukemia: A Real-World ExperienceIvan J Huang, Grace T Baek, Jonathan Cohen, et al.Cancer Immunology Research|May 20, 2016
Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of RituximabGregory A Rufener, Oliver W Press, Philip Olsen, et al.Blood Advances|June 17, 2025
Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomasChristina Poh, Jenna M Voutsinas, Mazyar Shadman, et al.Cancer Research|June 2, 2017
Venetoclax Synergizes with Radiotherapy for Treatment of B-cell LymphomasShyril O'Steen, Damian J Green, Ajay K Gopal, et al.Pageof 8